BioNTech will close its manufacturing plants in Germany and Singapore, affecting 1,860 jobs, after unsuccessful attempts to find buyers. This decision reflects ongoing challenges in the biotech sector and may impact future production capabilities.
Time has run out on BioNTech's bid to locate buyers for sites in Idar-Oberstein, Marburg and Tübingen. Including staff at a Singapore plant also slated for closure, the move could impact 1,860 jobs.
Original title: “BioNTech to close German manufacturing plants after failing to find buyers”